MBL Wealth LLC Decreases Stake in The Procter & Gamble Company (NYSE:PG)

MBL Wealth LLC lowered its position in The Procter & Gamble Company (NYSE:PGGet Rating) by 2.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,852 shares of the company’s stock after selling 140 shares during the quarter. MBL Wealth LLC’s holdings in Procter & Gamble were worth $870,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the company. Mutual Advisors LLC lifted its stake in Procter & Gamble by 2.4% in the first quarter. Mutual Advisors LLC now owns 53,800 shares of the company’s stock worth $7,999,000 after acquiring an additional 1,281 shares during the last quarter. Enterprise Bank & Trust Co lifted its stake in Procter & Gamble by 1.2% in the first quarter. Enterprise Bank & Trust Co now owns 6,921 shares of the company’s stock worth $1,029,000 after acquiring an additional 80 shares during the last quarter. Columbia Trust Co 01012016 lifted its stake in Procter & Gamble by 11.3% in the first quarter. Columbia Trust Co 01012016 now owns 11,313 shares of the company’s stock worth $1,682,000 after acquiring an additional 1,150 shares during the last quarter. MPS Loria Financial Planners LLC lifted its position in shares of Procter & Gamble by 2.8% during the 1st quarter. MPS Loria Financial Planners LLC now owns 3,492 shares of the company’s stock worth $519,000 after buying an additional 96 shares during the last quarter. Finally, Pure Financial Advisors LLC lifted its position in shares of Procter & Gamble by 18.6% during the 1st quarter. Pure Financial Advisors LLC now owns 9,352 shares of the company’s stock worth $1,391,000 after buying an additional 1,466 shares during the last quarter. Hedge funds and other institutional investors own 64.65% of the company’s stock.

Procter & Gamble Stock Performance

NYSE:PG opened at $149.95 on Friday. The firm’s fifty day simple moving average is $150.68 and its 200-day simple moving average is $147.42. The company has a quick ratio of 0.39, a current ratio of 0.59 and a debt-to-equity ratio of 0.51. The stock has a market cap of $353.43 billion, a PE ratio of 26.12, a price-to-earnings-growth ratio of 4.16 and a beta of 0.41. The Procter & Gamble Company has a fifty-two week low of $122.18 and a fifty-two week high of $158.11.

Procter & Gamble (NYSE:PGGet Rating) last issued its earnings results on Friday, April 21st. The company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.32 by $0.05. Procter & Gamble had a net margin of 17.69% and a return on equity of 32.18%. The company had revenue of $20.07 billion for the quarter, compared to analyst estimates of $19.32 billion. During the same period in the prior year, the business posted $1.33 earnings per share. The firm’s revenue for the quarter was up 3.5% compared to the same quarter last year. Analysts expect that The Procter & Gamble Company will post 5.86 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, May 15th. Shareholders of record on Friday, April 21st were issued a $0.9407 dividend. The ex-dividend date of this dividend was Thursday, April 20th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.91. This represents a $3.76 dividend on an annualized basis and a yield of 2.51%. Procter & Gamble’s dividend payout ratio (DPR) is 65.51%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 25,244 shares of the stock in a transaction dated Monday, April 24th. The shares were sold at an average price of $155.27, for a total value of $3,919,635.88. Following the completion of the transaction, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at $4,210,611.86. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, COO Shailesh Jejurikar sold 31,000 shares of the firm’s stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $156.03, for a total transaction of $4,836,930.00. Following the completion of the transaction, the chief operating officer now directly owns 10,014 shares of the company’s stock, valued at approximately $1,562,484.42. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Andre Schulten sold 25,244 shares of the firm’s stock in a transaction that occurred on Monday, April 24th. The stock was sold at an average price of $155.27, for a total transaction of $3,919,635.88. Following the transaction, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at $4,210,611.86. The disclosure for this sale can be found here. Over the last three months, insiders sold 95,093 shares of company stock valued at $14,821,930. Corporate insiders own 0.26% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Royal Bank of Canada boosted their price objective on shares of Procter & Gamble from $160.00 to $165.00 and gave the stock a “sector perform” rating in a research report on Monday, April 24th. Barclays boosted their price objective on shares of Procter & Gamble from $160.00 to $167.00 in a research report on Wednesday, April 26th. Jefferies Financial Group upped their price target on shares of Procter & Gamble from $171.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, April 24th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Procter & Gamble from $160.00 to $170.00 and gave the company a “buy” rating in a research report on Monday, April 24th. Finally, StockNews.com started coverage on shares of Procter & Gamble in a research report on Thursday, May 18th. They issued a “buy” rating for the company. Five analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $161.50.

Procter & Gamble Profile

(Get Rating)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGGet Rating).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.